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Yong Cui3* and Xuejun Zhang1,2*Abstract
Introduction: Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disease affecting predominantly
females. To discover additional genetic risk variants for SLE on the X chromosome, we performed a follow-up study of
our previously published genome-wide association study (GWAS) data set in this study.
Methods: Twelve single nucleotide polymorphisms (SNPs) within novel or unpublished loci with P-value < 1.00 × 10−02
were selected for genotype with a total of 2,442 cases and 2,798 controls(including 1,156 cases and 2,330 controls from
central China, 1,012 cases and 335 controls from southern China and 274 cases and 133 controls from northern China)
using Sequenom Massarry system. Associaton analyses were performed using logistic regression with sample region as
a covariate through PLINK 1.07 software.
Results: Combined analysis in discovery and central validation dataset discovered a novel locus rs5914778 within
LINC01420 associated with SLE at genome-wide significance (P = 1.00 × 10−08; odds ratio (OR) = 1.32). We also confirmed
rs5914778 in the southern Chinese sample cohort (P = 5.31 × 10−05; OR = 1.51), and meta-analysis of the samples from
the discovery, central and southern validations regions provided robust evidence for the association of rs5914778
(P = 5.26 × 10−12; OR = 1.35). However, this SNP did not show association with SLE in the northern sample (P = 0.33).
Further analysis represent the association of northern was significantly heterogeneous compared to central and
southern respectively.
Conclusions: Our study increases the number of established susceptibility loci for SLE in Han Chinese population and
has further demonstrated the important role of X-linked genetic risk variants in the pathogenesis of SLE in Chinese Han
population.
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Systemic lupus erythematosus (SLE) is a systemic auto-
immune disease that affects predominantly women aged
15–40 years, particularly women of child-bearing age.
SLE has been estimated to affect 31–70 cases per
100,000 people in China [1] with a ratio of 9:1 between
female and male patients. It is well known that both gen-
etic and environmental factors contribute to disease sus-
ceptibility [2–6]. Numerous variants on autosomal loci
have been found to be associated with SLE in multiple
ethnic groups through candidate gene and genome-wide
association studies (GWASs) [7]. Despite the advances
in the genetic studies over recent years, the pathogenesis
of SLE remains poorly understood.
Because of the huge gender difference in disease
prevalence, involvement of the genetic variants on the X
chromosome has long been suspected. In recent years,
genetic variants of several genes on the X chromosome,
such as MECP2, IRAK1, TLR7, and PRPS2, have been
confirmed to be associated with SLE [8–11]. In particu-
lar, single nucleotide polymorphism (SNP) rs3853839 on
the 3′ untranslated region (UTR) of TLR7 was shown to
be associated with SLE, especially in Chinese and
Japanese male subjects compared with females [10], and
a fine mapping study by Kaufman et al. [11] in four
different ancestral groups suggested that the nonsynon-
ymous SNP rs1059702 (S196F) within IRAK1 might be a
causal risk variant for SLE. More recently, we performed
a meta-analysis of GWASs in Chinese Han populations
and followed up the top findings in four additional Asian
cohorts [12]. Besides confirming the previously reported
associations within IRAK1-MECP2 (rs1059702) and
L1CAM-MECP2 loci, we also identified a genetic variant
(rs7062536) in PRPS2 on Xp22.3 as a novel susceptibility
locus and novel independent associations within the
NAA10 (rs2070028) and TMEM187 (rs17422) loci.
In this study, with the aim to discover additional X-
linked genetic risk variants for SLE, we performed a
follow-up study of our previously published GWAS
dataset by improving the coverage of genetic variation
through imputation and validating the top findings in an
additional three independent Chinese Han sampleTable 1 Summary of samples used in GWASs and replication studie
Cases
Stage Sample size Mean (SD) age Mean (SD) age of
GWAS 1017 34.19 (11.47) 29.84 (10.96)
Replication central 1156 35.19 (12.16) 30.70 (11.32)
Replication southern 1012 33.01 (10.82) 28.22 (10.03)
Replication northern 274 35.64 (12.02) 31.10 (11.79)
Total 3459 34.29 (11.60) 29.76 (10.94)
GWAS stage samples are from central China
GWAS genome-wide association study, SD standard deviationcollections [13]. We discovered a novel susceptibility
locus LINC01420 on Xp11.21 associated with SLE.
Methods
Subjects
SLE cases and controls were all female and were re-
cruited from multiple hospitals in three geographic re-
gions of China (central, southern, and northern China).
All subjects were of self-reported Chinese Han origin.
Samples in the GWAS discovery stage (1017 SLE cases
and 539 controls) were recruited from central China
[13]. Samples in the replication studies were recruited from
multiple regions in China, mainly from central (replication:
1156 cases and 2330 controls), southern (replication: 1012
cases and 335 controls), and northern (replication: 274
cases and 133 controls) China. All patients were diagnosed
as cases by at least two experienced physicians using the
American College of Rheumatology (ACR) criteria revised
in 1997 [14]. Controls also were geographically and
ethnically matched and clinically evaluated to be without
SLE, autoimmune disorders, or family history of auto-
immune diseases. Clinical information for all patients and
controls was collected through a structured questionnaire.
Written informed consent was acquired from all partici-
pants. This study was approved by the Institutional Ethical
Committee of The First Affiliated Hospital of Anhui
Medical University, China–Japan Friendship Hospital,
Jiangmen Central Hospital, and The Third Affiliated
Hospital of Sun Yat-Sen University, according to
Declaration of Helsinki principles. The information
for all subjects is summarized in Table 1.
Genotyping
The genotyping in the discovery stage for the central
China cohort was conducted by Illumina 610-Quad
Human Beadchip array (Illumina, Inc., San Diego, CA,
USA). The genomic DNA was isolated from peripheral
blood mononuclear cells (PBMCs) with standard pro-
cedures using Flexi Gene DNA kits (QIAGEN GmbH,
Hilden, Germany) and was diluted to working concen-
trations of 50 ng/μl for genome-wide genotyping and
15–20 ng/μl for the validation study. The SNPs in the Xs
Controls
onset Sex (female) Sample size Mean (SD) age Sex (female)
1017 539 34.31 (12.49) 539
1156 2330 29.34 (11.20) 2330
1012 335 32.59 (13.21) 335
274 133 29.48 (15.59) 133
3459 3337 30.47 (11.98) 3337
Table 2 Validation of top SNP rs5914778 in southern and northern regions of China
Central meta (discovery + central
validation)a
Southern validationb Northern validationc Meta (discovery + central + southern
validations)d
Meta (discovery + central + southern + northern
validations)e
Marker Gene
symbol
PVAL (FE) OR (FE) PVAL OR MAF
(case)
MAF
(control)
PVAL OR MAF
(case)
MAF
(control)
PVAL (FE) I2 (FE) PVAL (Het) OR (FE) PVAL (FE) I2 (FE) PVAL (Het) OR (FE)
rs5914778 LINC01420 1.00 × 10–8 1.32 5.31 × 10–5 1.51 0.352 0.265 3.28 × 10–1 0.85 0.252 0.284 5.26 × 10–12 0 4.62 × 10–1 1.35 1.22 × 10–10 65.3 3.44 × 10–2 1.31
aConsists of 2173 cases and 2869 controls
bConsists of 1012 cases and 335 controls
cConsists of 274 cases and 133 controls
dConsists of 3185 cases and 3204 controls
eConsists of 3459 cases and 3337 controls
FE fixed effects, Het heterogeneity, I2 heterogeneity statistic, MAF minor allele frequency, OR odds ratio, PVAL P value, SNP single nucleotide polymorphism
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Fig. 1 Manhattan plot of the X chromosome association analysis on
SLE. Manhattan plot of association results (−log10(P value)) are depicted with
regards to the physical location of SNPs and include both imputed and
genotyped association results. Positions and genes were based on National
Center for Biotechnology Information build 37 (http://www.ncbi.nlm.nih.gov/
assembly/GCF_000001405.25/). The color of gene labeling corresponds to
the gene type of known loci, suggestive loci, and novel loci. Known loci are
defined as loci published previously, whereby novel loci are defined as loci
in the current study validated at genome-wide significance (P <5× 10−8)
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using the Sequenom MassArray iPlex Gold platform
(Sequenom, Inc., San Diego, CA, USA).
Statistical analyses
Quality control criteria were applied to genotyped SNPs,
and those with minor allele frequency (MAF) <5 % in
cases and controls were excluded. SNPs with a genotype
missing rate >10 % or Hardy–Weinberg equilibrium
(HWE) P <3.14 × 10−6 in controls were also excluded.
Association analysis was performed in PLINK v1.07 [15]
using the logistic regression test. We selected 12 SNPs
within novel or unpublished loci with P <1.00 × 10−2 for
further validation in 2442 cases and 2798 controls (SNP
missing rate <10 % and HWE for female controls
with P >1.00 × 10−2).
To control the impact of population stratification in
the validation and combined analysis, we matched cases
and controls in terms of ethnic and geographic origins
as independent validation samples for combined analysis.
Fixed-effects meta-analysis of the four independent
studies in the discovery GWAS and three validation co-
horts (central, southern and northern) was performed
using the inverse variants weighted effect size method in
Metasoft version 2.0.0 [16].
We performed the combined analysis of the central
region (both discovery and central validation) cohort,
southern validation cohort, and northern validation
cohort using fixed-effects meta-analysis. The I2 hetero-
geneity statistic shows the heterogeneity across studies,
with I2 < 50 and Phet >0.05 considered insignificant
(Table 2).
Imputation
Imputation of the X chromosome SNPs was performed
on the discovery dataset for female individuals using X
chromosome nonpseudoautosomal region data from the
1000 Genomes project (phase 1 integrated version 3) as
reference [17]. As part of the quality control, SNPs with
accuracy score <0.8, missing rate >10 %, MAF <5 % in
cases and controls, or HWE P <2.89 × 10−7 in controls
were also excluded. Association was carried out by logis-
tic regression test. The imputation results show that
there is no substantial improvement of significant signals
between imputed or genotyped SNPs (Fig. 1). No im-
puted SNPs show better P values that would warrant
further validation on top of the genotyped SNPs. There-
fore, we proceeded with the validation of the selected
genotyped SNPs which resided in novel regions.
Results
X chromosome discovery and first-stage study
We conducted X chromosome association tests of SLE
in the GWAS dataset which consists of 1017 cases and539 controls, after stringent quality control filtering (see
Statistical analyses). The discovery analysis revealed strong
evidence of association for all previously identified suscep-
tibility loci on the X chromosome and suggested add-
itional novel risk loci (Additional file 1: Table S1).
To further investigate the observed associations, we
imputed the genotypes of additional SNPs that were not
genotyped using IMPUTE (v2.0) (Oxf, Oxford, Oxon, UK).
After stringent quality control filtering (imputation), no im-
puted SNPs show better P values that would warrant further
validation on top of the genotyped SNPs. Therefore, to
validate the findings from the discovery analysis, we selected
the top SNPs from 14 independent new loci with suggestive
association with SLE (P <10−2) for a follow-up analysis in an
additional 1156 cases and 2330 controls of Chinese Han
descent from central China. Of the 12 successfully geno-
typed SNPs, two showed association at P <0.05 in the
validation samples and six showed consistent effects
between the discovery and validation samples. The meta-
analysis results for the 12 SNPs in the combined discovery
and central validation dataset totaling 2173 cases and 2869
controls, using fixed-effects and random-effects models, are
presented in Table 3. The combined analysis discovered a
novel locus rs5914778 within LINC01420 associated with
SLE disease at genome-wide significance (P = 1.00 × 10−8;
odds ratio (OR) = 1.32).
Table 3 Validation of selected SNPs on the X chromosome in the central region
Discovery set (central)a Central validationb Meta (discovery + central validation)c
Marker Minor
allele
Position
(Hg19)
Annotation Gene
symbol
PVAL OR MAF
case
MAF
control
PVAL OR MAF
case
MAF
control
PVAL (FE) PVAL (RE) OR (FE) OR (RE) I2 PVAL (Het)
rs5914778 A 56758231 Intronic LINC01420 3.59 × 10–3 1.29 0.286 0.238 7.15 × 10–7 1.33 0.296 0.24 1.00 × 10–8 1.00 × 10–8 1.32 1.32 0 7.58 × 10–1
rs1527803 A 16421982 184 kb 3′ of CTPS2 NA 6.75 × 10–2 0.87 0.368 0.402 1.90 × 10–2 1.13 0.403 0.374 3.63 × 10–1 9.82 × 10–1 1.04 1.00 87.5 4.70 × 10–3
rs5963635 A 39166975 None LOC286442 1.40 × 10–3 1.34 0.247 0.197 2.17 × 10–1 1.08 0.230 0.217 5.17 × 10–3 1.08 × 10–1 1.15 1.19 74.1 4.94 × 10–2
rs1860995 G 119502122 Intronic ATP1B4 7.48 × 10–4 1.30 0.417 0.355 6.74 × 10–1 1.02 0.395 0.389 1.69 × 10–2 2.87 × 10–1 1.10 1.11 81.4 4.33 × 10–2
rs2536576 G 147417249 165 kb 5′ of AFF2 NA 5.73 × 10–3 1.34 0.172 0.134 9.43 × 10–1 1.01 0.152 0.152 1.12 × 10–1 3.36 × 10–1 1.10 1.15 80.2 2.45 × 10–2
rs17326228 G 106239318 Intronic MORC4 2.56 × 10–4 1.33 0.438 0.370 3.01 × 10–1 0.95 0.418 0.432 3.82 × 10–1 6.14 × 10–1 1.02 1.05 88.5 1.75 × 10–3
rs17329976 G 142130195 8.1 KB 3′ of SPANXN4 NA 4.28 × 10–2 0.83 0.179 0.209 1.58 × 10–1 0.91 0.160 0.174 2.23 × 10–2 3.62 × 10–2 0.85 0.83 51.6 1.62 × 10–1
rs5936901 G 67975499 30 kb 3′ of STARD8 NA 4.45 × 10–4 1.33 0.371 0.308 5.53 × 10–1 0.97 0.342 0.350 1.28 × 10–1 4.50 × 10–1 1.07 1.13 90.3 1.30 × 10–3
rs10218247 A 83476018 33 kb 5′ of RPS6KA6 NA 3.67 × 10–3 0.78 0.241 0.289 5.47 × 10–1 0.96 0.248 0.255 2.85 × 10–2 3.06 × 10–1 0.91 0.86 82.4 1.24 × 10–2
rs5970959 G 22987793 30 kb 5′ of DDX53 DDX53 1.42 × 10–2 1.25 0.254 0.215 1.57 × 10–1 0.92 0.251 0.267 3.76 × 10–1 6.41 × 10–1 1.03 1.05 86.7 2.06 × 10–3
rs6631753 A 33199451 Intronic DMD 6.94 × 10–3 0.81 0.376 0.426 5.09 × 10–1 1.04 0.374 0.366 7.12 × 10–2 4.69 × 10–1 0.93 0.91 89.2 4.35 × 10–3
rs2411864 G 16377763 206 kb 3′ of GRPR NA 5.04 × 10–3 0.76 0.154 0.194 4.81 × 10–1 1.05 0.165 0.159 2.98 × 10–1 5.16 × 10–1 0.94 0.90 86.2 7.10 × 10–3
aFrom Han et al. [13] with 1017 cases and 539 controls from central China
bConsists of 1156 cases and 2330 controls
cConsists of 2173 cases and 2869 controls
FE fixed effects, Het heterogeneity, I2 heterogeneity statistic, MAF minor allele frequency, NA not available, OR odds ratio, PVAL P value, RE random effects, SNP single nucleotide polymorphism
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Fig. 2 (See legend on next page.)
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Fig. 2 a Regional association plots of new loci (Xp11.21, LINC01420). The association results (−log10(P value)) of SNPs from the discovery analysis
were shown against their map positions (NCBI build 37). Validated SNP rs5914778 is labeled purple. b Regional association plots after conditioning
on rs5914778. The association results (−log10(P value)) of SNPs from the discovery analysis after conditioning on rs5914778. All map coordinates
are based on NCBI build 37. chrX X chromosome, NCBI National Center for Biotechnology Information
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heterogeneity test
We performed further replication analysis of rs5914778 in
two additional independent samples of Chinese Han des-
cent from the southern and northern regions of China.
The replication in the southern Chinese sample cohort,
consisting of a total of 1012 cases and 335 controls,
provided strong supporting evidence for the association
of rs5914778 with SLE (P = 5.31 × 10−5; OR = 1.51). The
meta-analysis of the samples from the central and
southern regions, totaling 3185 cases and 3204 controls,
provided robust evidence for the association of rs5914778
(P = 5.26 × 10−12; OR = 1.35). In addition, the strength of
the association is very consistent without any evidence of
heterogeneity (Phet = 0.46, I
2 = 0) (Table 2).
Intriguingly, this SNP did not show association with
SLE in the northern sample with a total of 274 cases and
133 controls (P = 0.33, OR = 0.85), and the SNP actually
showed an opposite effect in the northern sample as com-
pared with the central and southern samples (Table 2).
This could be because of the very small sample size of the
northern replication cohort. Further studies are needed to
confirm the heterogeneity of this association between the
northern and central/southern Chinese populations.
Lastly, we performed a joint analysis for all of the
discovery, central, southern, and northern validation
samples totaling 3459 cases and 3337 controls, using a
fixed-effects meta-analysis. The association at rs5914778
(LINC01420) on Xp11.21 surpassed the genome-wideFig. 3 Transcription factor binding sites of rs5913992 SNP (ENCODE). The tr
genome browser showed regions where transcription factors responsible fsignificance (P = 1.22 × 10−10; OR = 1.31), but a moderate
heterogeneity of association was observed within the
samples (Phet = 0.034, I
2 = 65.3) (Table 2 and Fig. 2).
Discussion
Through the discovery and validation analyses in two
independent female samples from the central region of
China, we have discovered a novel SLE susceptibility locus
at rs5914778 (LINC01420) on Xp11.21 at the genome-wide
significance. Further replication analysis in the independent
sample of southern Chinese confirmed the association with
strong evidence. The analysis of the independent sample of
northern Chinese failed to replicate the association, but the
sample size of the northern cohort is very small.
rs5914778 is located within a long intronic region be-
tween the first and second exons of LINC01420.
LINC01420 is a long noncoding RNA with enhancers
marked by histone modifications in human umbilical vein
endothelial cells (HUVEC) and HSMM based on Hap-
loReg annotation [18] (Additional file 2: Table S2).
LINC01420 was found to have sex-specific DNAse I
hypersensitivity patterns which showed H3K4me3 histone
enrichment and strong expression in females only [19].
According to the regulatory annotation information from
the ENCODE project [20], this SNP is within a DNase I
hypersensitive site that was detected in the lymphoblas-
toid cell line. LINC01420 may maintain the X inactivation
which avoids X-linked gene overexpression through dos-
age compensation in females [21]. Long noncoding RNAsanscription track from the UCSC (University of California, Santa Cruz)
or modulating gene transcription bind to DNA as assayed by ChIP-seq
Zhu et al. Arthritis Research & Therapy  (2015) 17:349 Page 8 of 9have been shown to be associated with many complex dis-
eases such as psoriasis, breast cancer, gastric cancer, colo-
rectal cancer, osteosarcoma, adrenocortical cancer, and
cardiovascular diseases in recent years [22–28]. Some non-
coding RNAs also play a role in the pathogenesis and pro-
gression of hepatocellular carcinoma, and may act as
therapeutic targets for hepatocellular carcinoma [29]. In
order to reveal whether there are expression difference of
LINC01420 between females and males, we performed
gene expression analyses using the gene expression data
from CD4+ T cells and monocytes from 461 healthy indi-
viduals [30] and the gene expression data from PBMCs of
82 controls [31] in GEO datasets. However, we did not
obtain the gene expression result of LINC01420, indicating
that LINC01420 might express too low to be detected in
blood cells from healthy individuals. Hence, more work
will be needed to elucidate the biological mechanism
through which LINC01420 influences SLE pathogenesis.
We also observed another SNP, rs5913992, in perfect link-
age disequilibrium with our top SNP rs5914778 (R2 = 1) that
was predicted to be functional by Regulome DB (LSJU,
Stanford, CA, USA) with a score of 2b (likely to affect
binding of motifs, transcription factors, and enhancer his-
tone marks) in this locus [32]. rs5913992 is also within the
region of the binding sites of six overlapping transcription
factors (transcription factor binding sites)—RELA, CTCF,
CEBPB, RAD21, ZNF143, and SMC3—that were detected
by ChIP-Seq analysis in lymphoblastoid, epithelial, endo-
thelial, breast cancer, and myeloid leukemia cell lines
(Fig. 3). The prediction by Regulome DB indicates that
this SNP overlaps a potential consensus EWSR1-FLI1
binding motif within the binding sites of the six transcrip-
tion factor binding sites (Additional file 3: Table S3).
We observed the same risk effect at rs5914778 in the
central and southern validation results, while the opposite
effect was observed in the northern validation results. The
association of the northern cohort was significantly hetero-
geneous compared with the central and southern cohorts
respectively (Phet = 0.034, I
2 = 65.3). Several previous studies
have demonstrated differences in disease risk between
northern and southern Chinese, and further studies in
more northern Chinese samples will be needed to confirm
the genetic heterogeneity of this susceptibility locus
among the central, southern, and northern Chinese popu-
lations [33–35].
Conclusions
We performed a three-stage X chromosome association
analysis of SLE in the Chinese Han population and discov-
ered a novel susceptibility locus on Xp11.21. Although fur-
ther studies will be required to understand how the locus
influences the etiology of SLE, the discovery of this novel
locus has further expanded the role of the X chromosome
in the development of SLE in the Chinese Han population.Additional files
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